China approves testing of COVID-19 vaccine in the form of nasal spray

A vaccine developed in China against COVID-19 in the form of a nasal spray has been approved for clinical trials in the country, Xinhua news agency reported, citing a statement from the University of Hong Kong (HKU).

It is reported that the vaccine was developed by the HKU laboratory in collaboration with Xiamen University and the pharmaceutical company Beijing Wantai Biological Pharmacy.

As the Agency points out, this is the first COVID-19 vaccine in the form of a nasal spray that has been approved by the state food and drug administration for human clinical trials.

Earlier, the company China National Biotec Group reported that six vaccines developed in China against COVID-19 is at the stage of clinical trials.

Tags: